Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus
about
An influenza A/H1N1/2009 hemagglutinin vaccine produced in Escherichia coliA single immunization with soluble recombinant trimeric hemagglutinin protects chickens against highly pathogenic avian influenza virus H5N1Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccinesExpression of avian influenza virus (H5N1) hemagglutinin and matrix protein 1 in Pichia pastoris and evaluation of their immunogenicity in mice.Evaluation of antibody response in mice against avian influenza A (H5N1) strain neuraminidase expressed in yeast Pichia pastoris.Trichoplusia ni cells (High Five) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccinesProperly folded bacterially expressed H1N1 hemagglutinin globular head and ectodomain vaccines protect ferrets against H1N1 pandemic influenza virusA novel hemagglutinin protein produced in bacteria protects chickens against H5N1 highly pathogenic avian influenza viruses by inducing H5 subtype-specific neutralizing antibodiesExpression of HA1 antigen of H5N1 influenza virus as a potent candidate for vaccine in bacterial system.Vaccination with Killed but Metabolically Active E. coli Over-expressing Hemagglutinin Elicits Neutralizing Antibodies to H1N1 Swine Origin Influenza A VirusVaccination with drifted variants of avian H5 hemagglutinin protein elicits a broadened antibody response that is protective against challenge with homologous or drifted live H5 influenza virus.Yeast expressed recombinant Hemagglutinin protein of novel H1N1 elicits neutralising antibodies in rabbits and mice.Cell-free production of trimeric influenza hemagglutinin head domain proteins as vaccine antigens.Influence of copy number on the expression levels of pandemic influenza hemagglutinin recombinant protein in methylotrophic yeast Pichia pastoris.Influenza A virus nucleoprotein derived from Escherichia coli or recombinant vaccinia (Tiantan) virus elicits robust cross-protection in miceA baseline process for the production, recovery, and purification of bacterial influenza vaccine candidates.Different immunity elicited by recombinant H5N1 hemagglutinin proteins containing pauci-mannose, high-mannose, or complex type N-glycansAntigenic and immunogenic properties of recombinant hemagglutinin proteins from H1N1 A/Brisbane/59/07 and B/Florida/04/06 when produced in various protein expression systems.A recombinant vaccine of H5N1 HA1 fused with foldon and human IgG Fc induced complete cross-clade protection against divergent H5N1 viruses.Recombinant trimeric HA protein immunogenicity of H5N1 avian influenza viruses and their combined use with inactivated or adenovirus vaccines.Chimpanzees as an animal model for human norovirus infection and vaccine development.Robust immunity and heterologous protection against influenza in mice elicited by a novel recombinant NP-M2e fusion protein expressed in E. coliDendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single doseRoles of the hemagglutinin of influenza A virus in viral entry and development of antiviral therapeutics and vaccines.Developments of subunit and VLP vaccines against influenza A virus.Vaccines based on structure-based design provide protection against infectious diseases.Characterization of Monoclonal Antibodies against HA Protein of H1N1 Swine Influenza Virus and Protective Efficacy against H1 Viruses in Mice.Expression and purification of recombinant H5HA1 protein of H5N1 avian influenza virus in E. coli and its application in indirect ELISA.Study of immunogenicity of recombinant proteins based on hemagglutinin and neuraminidase conservative epitopes of influenza A virusA nonfusogenic antigen mimic of influenza hemagglutinin glycoproteins constituted with soluble full-length HA1 and truncated HA2 proteins expressed in E. coli.ELPylated haemagglutinins produced in tobacco plants induce potentially neutralizing antibodies against H5N1 viruses in mice.
P2860
Q28750246-FE289574-1440-4FFE-9D48-52D21F5C0631Q28752179-F478F7C1-4405-43F2-ACA7-60B5AC6AC95BQ30356933-AB898CC5-14CA-4B08-992F-732699DB53A5Q30359355-E3E6610D-2E9E-4461-AC86-572BF16CAA72Q30362744-706E76A9-087A-4FBA-8ED8-7CE25D6CEB4AQ30387030-AD9D5ADF-F152-40F4-B482-BC314367B55DQ30391443-C8B4303E-26A0-4A1A-9378-64033F4D15F3Q30398811-5F53969A-C0BC-4215-890B-D7EFE3DDEE7AQ30398957-A6DA0803-083E-4DF6-A3CD-11689B927A36Q30401849-C5D6632F-351C-419F-9EFD-684DA2D6198FQ30407657-9BCC9C30-082B-4AF8-B2F1-E51D25F6FEAAQ30410094-75535A4E-493D-4FDF-AEDF-0A73F4F1010AQ30418486-CD4275C3-24BC-4957-8E77-97C2F8C3B8EEQ30420854-27613CB9-7CB2-4138-B5F8-2ADAEFAF877FQ30425194-6300317D-98C5-4B9D-BB59-412E6025B45CQ30431659-FAE99CF3-E0BB-4A46-B1BA-6F320089875CQ30432386-3E9DD58F-910C-4D39-865D-29CB61BE7ACEQ30517014-2B92E94A-6165-4982-8632-19DEC1D4C0DAQ33815195-8843261E-D339-4181-BABF-7B85236CBA88Q33927420-637B0BA2-8FB9-4A73-8CCA-8BE01AED385AQ34471908-CACFA73F-5802-4701-9B86-5B080370D54FQ34533990-8DABCF40-DC48-4342-B89C-10587BD1B126Q37126611-A3241FB3-B692-45C1-B032-9D68942CCA9AQ37825824-AD4C7529-9B04-4C43-B065-5CE85B712AFFQ38017605-324B92F0-6527-4B82-B70F-CA0B4A22509CQ38148782-7215CA20-5E83-4E4C-A172-A28E167D22EEQ40091003-C0FBAF56-6067-4760-BE52-793F1E2ED9EEQ40939614-FD82C2D9-2B4B-4305-B678-53E2D6846965Q42113474-3866C06E-8F92-45F8-A689-62AAFA005569Q42184367-6BB731A1-4A55-49C7-91F6-073E3D545EFFQ45009234-781BD58B-4FD5-402C-BAFD-55BA3D6845CC
P2860
Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Preparation, characterization, ...... tnam/1203/2004 influenza virus
@ast
Preparation, characterization, ...... tnam/1203/2004 influenza virus
@en
type
label
Preparation, characterization, ...... tnam/1203/2004 influenza virus
@ast
Preparation, characterization, ...... tnam/1203/2004 influenza virus
@en
prefLabel
Preparation, characterization, ...... tnam/1203/2004 influenza virus
@ast
Preparation, characterization, ...... tnam/1203/2004 influenza virus
@en
P2093
P2860
P1433
P1476
Preparation, characterization, ...... tnam/1203/2004 influenza virus
@en
P2093
Jerry M Keith
John B Robbins
Joseph Shiloach
Kim Y Green
Mark A Miller
Zuzana Biesova
P2860
P304
P356
10.1016/J.VACCINE.2009.07.107
P407
P577
2009-08-15T00:00:00Z